Advertisement
UK markets closed
  • FTSE 100

    8,146.86
    -16.81 (-0.21%)
     
  • FTSE 250

    20,120.36
    -75.54 (-0.37%)
     
  • AIM

    776.04
    -4.39 (-0.56%)
     
  • GBP/EUR

    1.1845
    -0.0034 (-0.29%)
     
  • GBP/USD

    1.2686
    -0.0074 (-0.58%)
     
  • Bitcoin GBP

    52,623.36
    +393.40 (+0.75%)
     
  • CMC Crypto 200

    1,381.99
    -35.88 (-2.53%)
     
  • S&P 500

    5,431.60
    -2.14 (-0.04%)
     
  • DOW

    38,589.16
    -57.94 (-0.15%)
     
  • CRUDE OIL

    78.49
    -0.13 (-0.17%)
     
  • GOLD FUTURES

    2,348.40
    +30.40 (+1.31%)
     
  • NIKKEI 225

    38,814.56
    +94.06 (+0.24%)
     
  • HANG SENG

    17,941.78
    -170.82 (-0.94%)
     
  • DAX

    18,002.02
    -263.68 (-1.44%)
     
  • CAC 40

    7,503.27
    -204.75 (-2.66%)
     

Kits Eyecare First Quarter 2024 Earnings: EPS: CA$0.002 (vs CA$0.033 loss in 1Q 2023)

Kits Eyecare (TSE:KITS) First Quarter 2024 Results

Key Financial Results

  • Revenue: CA$34.8m (up 26% from 1Q 2023).

  • Net income: CA$64.0k (up from CA$1.02m loss in 1Q 2023).

  • Profit margin: 0.2% (up from net loss in 1Q 2023). The move to profitability was driven by higher revenue.

  • EPS: CA$0.002 (up from CA$0.033 loss in 1Q 2023).

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

Kits Eyecare Earnings Insights

Looking ahead, revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 7.5% growth forecast for the Specialty Retail industry in Canada.

Performance of the Canadian Specialty Retail industry.

ADVERTISEMENT

The company's shares are up 4.7% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Kits Eyecare's balance sheet.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.